Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Liselot Mus

41 Results

2022

Complementarity of single-nucleus and single-cell RNA sequencing to study the transcriptional heterogeneity of neuroblastoma tumors

Noah BonineTinne ThonéBavo VannesteLiselot MusCeline EveraertBram De WildeFranki SpelemanCharlotte ScottKatleen De Preter

Complementarity of single-nucleus and single-cell RNA sequencing to study the transcriptional heterogeneity of neuroblastoma tumors

Noah BonineTinne ThonéBavo VannesteLiselot MusCeline EveraertBram De WildeFranki SpelemanCharlotte ScottKatleen De Preter

RRM2 enhances MYCN driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

Lisa DepestelCarolina de Carvalho NunesLiselot MusIris NelenLouis DelhayeFanny De VloedEllen SandersAline EggermontSiebe LoontiensSofia ZanottiBieke DecaestekerLaurentijn TillemanDieter DeforceBram De WildeSven EyckermanVanessa VermeirssenKaat DurinckFranki Speleman

RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

Carolina de Carvalho NunesLisa DepestelLiselot MusLouis DelhayeAmber LouwagieMuhammad RishfiFanny De VloedEllen SandersAline EggermontSarah-Lee BekaertWouter Van LoockeJan Willem BekGivani DewynSiebe LoontiensGert Van IsterdaelBieke DecaestekerLaurentijn TillemanFilip Van NieuwerburghVanessa VermeirssenChristophe Van NesteBart GhesquièreSteven GoossensSven EyckermanKatleen De PreterBram De WildeKaat DurinckFranki Speleman

U Journal Article in Science Advances

The TEARDRoP (Team early drug development in Paediatric oncology) consortium : to help Research find its way to improved treatments for children with cancer

Liselot MusBram De WildeCatherine Van Der StraetenBarbara De MoerlooseSylvie Rottey

2021

MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cells

Sofia ZanottiSuzanne VanhauwaertChristophe Van NesteVolodimir OlexioukJolien Van LaereJoni Van der MeulenLiselot MusKaat DurinckLaurentijn TillemanDieter DeforceFilip Van NieuwerburghBieke DecaestekerFranki Speleman

A1 Journal Article in SCIENTIFIC REPORTS

Recurrent chromosomal imbalances provide selective advantage to human embryonic stem cells under enhanced replicative stress conditions

Liselot MusStéphane Van HaverMina PopovicWim TrypsteenSteve LefeverEva JacobsEllen SandersChristophe Van NesteSuzanne VanhauwaertBieke DecaestekerDieter DeforceFilip Van NieuwerburghPieter MestdaghJo VandesompeleBjörn MentenKatleen De PreterBjörn HeindryckxKaat DurinckFranki Speleman

A1 Journal Article in GENES CHROMOSOMES & CANCER

SOX11 as guardian of epigenetic plasticity in neuroblastoma

Bieke DecaestekerAmber LouwagieSiebe LoontiensCarolina de Carvalho NunesFanny De VloedLisa DepestelJuliette RoelsKaren VerboomEva D'haeneWouter Van LoockeVolodimir OlexioukPauline DepuydtEllen SandersGivani DewynLiselot MusLucia LorenziJo Van DorpeDavid CreytensKaat DurinckBjörn MentenNadine Van RoyTim PietersPieter Van VlierbergheSuzanne VanhauwaertChristophe Van NesteKatleen De PreterFranki Speleman

2020

Genetic events contributing to tumour promotion and aggressiveness in high-risk neuroblastoma

Liselot MusFranki SpelemanKaat DurinckBart Roman

The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness

Liselot MusIrina LambertzShana ClaeysCandy KumpsWouter Van LoockeChristophe Van NesteGenevieve LaureysOlivier De WeverBram De WildeKaat DurinckKatleen De PreterFranki Speleman

A1 Journal Article in SCIENTIFIC REPORTS

2019

17q gain provides proliferative advantage to human embryonic stem cells under conditions of replicative stress

Liselot MusStéphane Van HaverEllen SandersEva JacobsMina PopovicChristophe Van NesteSuzanne VanhauwaertKaat DurinckBjörn MentenKatleen De PreterBjörn HeindryckxFranki Speleman

17q gain provides proliferative advantage to human embryonic stem cells under replicative stress

Liselot MusStéphane Van HaverGeertrui DeneckerEllen SandersEva JacobsMina PopovicChristophe Van NesteSuzanne VanhauwaertVanessa VermeirssenKaat DurinckBjörn MentenKatleen De PreterBjörn HeindryckxFranki Speleman

ALK positively regulates MYCN activity through repression of HBP1 expression

Shana ClaeysKaat DurinckBieke DecaestekerLiselot MusSiebe LoontiensSuzanne VanhauwaertCandy KumpsTom Van MaerkenGenevieve LaureysChristophe Van NesteBram De WildeOlivier De WeverKatleen De PreterFranki Speleman

A1 Journal Article in ONCOGENE

Exploring the contribution of gene dosage effects of 17q gain genes on hESC and neuroblastoma proliferation

Liselot MusStéphane Van HaverEllen SandersEva JacobsMina PopovicChristophe Van NesteSuzanne VanhauwaertKaat DurinckBjörn MentenKatleen De PreterBjörn HeindryckxFranki Speleman

SOX11 as mediator of the adrenergic cell state in NB

Bieke DecaestekerAmber LouwagieSara De BrouwerVolodimir OlexioukGeertrui DeneckerCarolina de Carvalho NunesKaren VerboomWouter Van LoockePauline DepuydtFanny De VloedEllen SandersSuzanne VanhauwaertLiselot MusSiebe LoontiensBram De WildeGenevieve LaureysBjörn MentenNadine Van RoyJo Van DorpeDavid CreytensChristophe Van NesteKaat DurinckKatleen De PreterFranki Speleman

SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma

Amber LouwagieBieke DecaestekerCarolina de Carvalho NunesGeertrui DeneckerVolodimir OlexioukKaren VerboomWouter Van LoockePauline DepuydtFanny De VloedEllen SandersLiselot MusSiebe LoontiensLucia LorenziJo Van DorpeDavid CreytensBjörn MentenNadine Van RoyKaat DurinckSuzanne VanhauwaertChristophe Van NesteKatleen De PreterFranki Speleman

SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma

Amber LouwagieBieke DecaestekerSara De BrouwerGeertrui DeneckerCarolina de Carvalho NunesVolodimir OlexioukKaren VerboomWouter Van LoockePauline DepuydtFanny De VloedEllen SandersSuzanne VanhauwaertLiselot MusSiebe LoontiensBjörn MentenNadine Van RoyDavid CreytensKaat DurinckKatleen De PreterFranki Speleman

2018

Exploring the contribution of gene dosage effects of 17Q gain on ESC and neuroblastoma proliferation

Liselot MusGeertrui DeneckerStéphane Van HaverEllen SandersEva JacobsMina PopovicChristophe Van NesteSuzanne VanhauwaertKaat DurinckBjörn MentenKatleen De PreterBjörn HeindryckxFranki Speleman

Exploring the contribution of gene dosage effects of 17q gain genes on hESC and neuroblastoma proliferation

Liselot MusStéphane Van HaverEllen SandersEva JacobsMina PopovicChristophe Van NesteSuzanne VanhauwaertKaat DurinckBjörn MentenKatleen De PreterBjörn HeindryckxFranki Speleman

Exploring the contribution of gene dosage effects of 17q gain on ESC and neuroblastoma proliferation

Liselot MusGeertrui DeneckerStéphane Van HaverEllen SandersEva JacobsMina PopovicChristophe Van NesteSuzanne VanhauwaertKaat DurinckBjörn MentenKatleen De PreterBjörn HeindryckxFranki Speleman

Exploring the contribution of gene dosage effects of 17q gain on ESC and neuroblastoma proliferation

Liselot MusGeertrui DeneckerStéphane Van HaverEllen SandersEva JacobsMina PopovicChristophe Van NesteSuzanne VanhauwaertKaat DurinckBjörn MentenKatleen De PreterBjörn HeindryckxFranki Speleman

IncuCyte® : when real-time, automated live-cell imaging and analysis becomes easy

Vehicle development, pharmacokinetics and toxicity of the anti-invasive agent 4-fluoro-3’,4’,5’-trimethoxychalcone in rodents

Liselot MusGeertrui DeneckerFranki SpelemanBart Roman

A1 Journal Article in PLOS ONE

2017

EV-TRACK : transparent reporting and centralizing knowledge in extracellular vesicle research

Jan Van DeunPieter MestdaghEls BegheinLaurence BertierGeert BerxClara CasertBert DhondtEdward GeeurickxJan GettemansFarzaneh GhazaviHetty HelsmoortelCarina LeonelliLien LippensGloria MilaniLiselot MusQuentin RousseauBieke SoenAnneleen SteelsJoeri TulkensIsabel Van AudenhoveAlan Van GoethemNadine Van RoyNiels VandammeSuzanne VanhauwaertGlenn VergauwenAnnelynn WallaertOlivier De WeverJo VandesompeleAn Hendrix

A1 Journal Article in NATURE METHODS

The ETV5 oncogene is a target of activated ALK signaling in neuroblastoma

Liselot MusIrina LambertzCandy KumpsShana ClaeysGeertrui DeneckerWouter Van LoockeChristophe Van NesteNadine Van RoyBram De WildeGenevieve LaureysOlivier De WeverKatleen De PreterFranki Speleman

The ETV5 oncogene is a target of activated ALK signaling in neuroblastoma

Liselot MusIrina LambertzCandy KumpsShana ClaeysGeertrui DeneckerWouter Van LoockeChristophe Van NesteNadine Van RoyBram De WildeGenevieve LaureysOlivier De WeverKatleen De PreterFranki Speleman

The ETV5 oncogene is a target of activated ALK signaling in neuroblastoma

Liselot MusIrina LambertzCandy KumpsShana ClaeysGeertrui DeneckerWouter Van LoockeChristophe Van NesteNadine Van RoyBram De WildeGenevieve LaureysOlivier De WeverKatleen De PreterFranki Speleman

2016

4-Fluoro-3',4',5'-trimethoxychalcone as a new anti-invasive agent : from discovery to initial validation in an in vivo metastasis model

Bart RomanLiselot MusTine De RyckMarc BrackeChristian Stevens

4-Fluoro-3',4',5'-trimethoxychalcone as a new anti-invasive agent: from discovery to initial validation in an in vivo metastasis model

Bart RomanLiselot MusTine De RyckMarc BrackeChristian Stevens

4-Fluoro-3',4',5'-trimethoxychalcone as a new anti-invasive agent: from discovery to initial validation in an in vivo metastasis model

Bart RomanLiselot MusMarc BrackeChristian Stevens

Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samples

Alan Van GoethemNurten YigitCeline EveraertLiselot MusFranki SpelemanPieter MestdaghTom Van MaerkenJo Vandesompele

A1 Journal Article in SCIENTIFIC REPORTS

Discovery and development of new anti-invasive agents, an unmet clinical need

Bart RomanLiselot MusTine De RyckMarc BrackeChristian Stevens

Dual targeting of ALK and RET: establishing a novel basis for the treatment of neuroblastoma

Liselot MusShana ClaeysBram De WildeGenevieve LaureysAlan Van GoethemKatleen De PreterIrina LambertzFranki Speleman

Dual targeting of ALK and RET: establishing a novel basis for the treatment of neuroblastoma

Liselot MusShana ClaeysBram De WildeGenevieve LaureysAlan Van GoethemKatleen De PreterIrina LambertzFranki Speleman

ETV5 functionally connect ALK and CXCR4 signaling in neuroblastoma

Irina LambertzShana ClaeysCandy KumpsLiselot MusNadine Van RoyBram De WildeGenevieve LaureysOlivier De WeverKatleen De PreterFranki Speleman

ETV5 functionally connects ALK and CXCR4 signaling in neuroblastoma

Irina LambertzLiselot MusCandy KumpsShana ClaeysBram De WildeGenevieve LaureysOlivier De WeverKatleen De PreterFranki Speleman

Pharmacological evaluation of the anti-invasive agent 4-fluoro-3',4',5'-trimethoxychalcone

Bart RomanLiselot MusTine De RyckMarc BrackeChristian Stevens

Sensing mutant ALK: Capicua and ETV5 as executors of aberrant ALK-driven MAPK signaling

Irina LambertzLiselot MusCandy KumpsShana ClaeysWouter Van LoockeChristophe Van NesteNadine Van RoyBram De WildeGenevieve LaureysOlivier De WeverKatleen De PreterFranki Speleman

2015

Addition of NaCl upregulates NFAT5 expression in Duchenne muscular dystrophy cultured myotubes

dr. Sandrine HerbeletBoel De PaepeElly De VlieghereLiselot MusLynn FeysOlivier De WeverJan De Bleecker

Chick heart invasion assay for testing the invasiveness of cancer cells and the activity of potentially anti-invasive compounds

Marc BrackeBart RomanChristian StevensLiselot MusOlivier De WeverMarcus Mareel

A1 Journal Article in JOVE-JOURNAL OF VISUALIZED EXPERIMENTS

ETV5 functionally connect ALK and RET signaling in neuroblastoma

Irina LambertzShana ClaeysCandy KumpsLiselot MusAnneleen BeckersNadine Van RoyGenevieve LaureysOlivier De WeverKatleen De PreterFranki Speleman